NEFL and myeloid sarcoma: During this prodromal or subclinical phase of MS, CNS inflammation and neuroaxonal damage is initiated, as demonstrated by elevated levels of the axonal injury biomarker neurofilament light chain (NFL) years before the clinical onset (10, 11).